CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
Electrical Stimulation - Active +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03821675
NCT03821675N/ACompleted
CompareCT.gov

Electrical Stimulation as an Adjunctive Therapy to Accelerate Wound Healing in People With Diabetic Foot Ulcers - A Randomized Controlled Trial

Baylor College of Medicine·interventional·Posted Jan 30, 2019·Updated May 9, 2022

In Brief

A clinical study evaluating Electrical Stimulation - Active and Electrical Stimulation - Sham for Diabetes and 3 related conditions. Completed, enrolled 38 participants across 1 site.

Detailed Summary

A clinical study at the Baylor College of Medicine, Division of Vascular Surgery and Endovascular Therapy, is being proposed to test the efficacy of a novel electrical stimulation platform named the Tennant Biomodulator designed by AVAZZIA to accelerate wound healing, relieve pain and improve mobility in patients with diabetic foot ulcers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Diabetic Foot Ulcer, Peripheral Neuropathy, Peripheral Arterial Disease
CountriesUnited States
CollaboratorsAvazzia, Inc

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 30, 2019
Enrollment StartFeb 28, 2019
Primary CompletionMar 15, 2020
Study CompletionOct 8, 2021
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 7.4 years ago

Interventions

Electrical Stimulation - Activedevice

Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.

Electrical Stimulation - Shamdevice

Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.